News Column

Gilead Sciences to Present at the Wells Fargo Healthcare Conference on Tuesday, June 17

July 2, 2014

By a News Reporter-Staff News Editor at Biotech Week -- Gilead Sciences, Inc. (Nasdaq: GILD) announced that its corporate presentation will be webcast from the Wells Fargo Healthcare Conference in Boston (see also Pharmaceutical Companies).

John C. Martin, PhD, Gilead's Chairman and Chief Executive Officer, will provide an overview of the company at the conference on Tuesday, June 17 at 10:00 a.m. Eastern Time.

To access the live webcast or a replay via the internet log on to Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast. The replay will be available for 14 days following the presentation. About Gilead Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North and South America, Europe and Asia Pacific. For more information on Gilead Sciences, please visit or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

Keywords for this news article include: Banking and Finance, Gilead Sciences Inc., Biotechnology Companies, Biopharmaceutical Companies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Biotech Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters